Clinical pharmacokinetics of tacrolimus, Clin Pharmacokinet, vol.29, issue.6, pp.404-434, 1995. ,
Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation, J Am Soc Nephrol, vol.16, issue.6, pp.1839-1887, 2005. ,
AN OPEN-LABEL, CONCENTRATION-RANGING TRIAL OF FK506 IN PRIMARY KIDNEY TRANSPLANTATION, Transplantation, vol.62, issue.7, pp.900-905, 1996. ,
DOI : 10.1097/00007890-199610150-00005
Tacrolimus Once-Daily Formulation in the Prophylaxis of Transplant Rejection in Renal or Liver Allograft Recipients, Drugs, vol.7, issue.6, pp.1944-1949, 2007. ,
DOI : 10.2165/00003495-200767130-00014
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients, Transplantation, vol.83, issue.12, pp.1648-51, 2007. ,
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference, Therapeutic Drug Monitoring, vol.31, issue.2, pp.139-52, 2009. ,
DOI : 10.1097/FTD.0b013e318198d092
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression, Nat Genet, vol.27, issue.4, pp.383-91, 2001. ,
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus, Clin Pharmacol Ther, vol.74, issue.3, pp.245-54, 2003. ,
Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients, Ther Drug Monit Musuamba FT, Mourad M, vol.31, issue.11, pp.187-97, 2009. ,
Population pharmacokinetics and bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation, Clin Pharmacokinet, vol.49, issue.10, pp.683-92 ,
URL : https://hal.archives-ouvertes.fr/inserm-00926496
Population pharmacokinetics of tacrolimus in adult kidney transplant recipients, Clinical Pharmacology & Therapeutics, vol.72, issue.6, pp.660-669, 2002. ,
DOI : 10.1067/mcp.2002.129304
Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients, British Journal of Clinical Pharmacology, vol.23, issue.0, pp.750-757, 2007. ,
DOI : 10.1016/S0041-1345(02)02999-8
Tacrolimus population pharmacokineticpharmacogenetic analysis and Bayesian estimation in renal transplant recipients, Clin Pharmacokinet, vol.48, issue.16, pp.805-821, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-01390737
Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies Pharmacokinetic modeling and development of bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation, Clin Pharmacokinet Ther Drug Monit, vol.4432, issue.172, pp.1317-28129, 2005. ,
NONMEM User's Guide -Part V: Introductory Guide.; 1994. 20 ,
Evaluation of Mixture Modeling with Count Data Using NONMEM, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.3, pp.18-69 ,
DOI : 10.1023/A:1025564409649